Summarized by Masters of Longevity from Longevity Docs News.
A Columbia spinout reports unpublished mouse data on nasal semaglutide delivery.
Key Takeaways
- LionBio is developing a nasal nanoparticle to deliver semaglutide.
- Reported efficacy and distribution findings are from unpublished mouse studies.
- Human relevance is uncertain because rodent nasal delivery often fails.
